Boreskov Institute of Catalysis SB RAS, 5 Acad. Lavrentiev Pr., 630090, Novosibirsk, Russia.
International Tomography Center SB RAS, 3A Institutskaya St., 630090, Novosibirsk, Russia.
Angew Chem Int Ed Engl. 2021 Feb 1;60(5):2406-2413. doi: 10.1002/anie.202011698. Epub 2020 Dec 1.
Nimorazole belongs to the imidazole-based family of antibiotics to fight against anaerobic bacteria. Moreover, nimorazole is now in Phase 3 clinical trial in Europe for potential use as a hypoxia radiosensitizer for treatment of head and neck cancers. We envision the use of [ N ]nimorazole as a theragnostic hypoxia contrast agent that can be potentially deployed in the next-generation MRI-LINAC systems. Herein, we report the first steps to create long-lasting (for tens of minutes) hyperpolarized state on three N sites of [ N ]nimorazole with T of up to ca. 6 minutes. The nuclear spin polarization was boosted by ca. 67000-fold at 1.4 T (corresponding to P of 3.2 %) by N- N spin-relayed SABRE-SHEATH hyperpolarization technique, relying on simultaneous exchange of [ N ]nimorazole and parahydrogen on polarization transfer Ir-IMes catalyst. The presented results pave the way to efficient spin-relayed SABRE-SHEATH hyperpolarization of a wide range of imidazole-based antibiotics and chemotherapeutics.
硝咪乙脲属于咪唑类抗生素家族,可用于对抗厌氧菌。此外,硝咪乙脲目前正在欧洲进行 3 期临床试验,有望作为缺氧放射增敏剂用于治疗头颈部癌症。我们设想将[15N]硝咪乙脲用作治疗性缺氧对比剂,可潜在应用于下一代 MRI-LINAC 系统。本文首次报道了在[15N]硝咪乙脲的三个[N]位点上产生长达数十分钟的持久(长达 6 分钟)高极化状态的方法。通过 N- N 自旋相关的 SABRE-SHEATH 极化技术,在 1.4 T 下将核自旋极化提高了约 67000 倍(对应于 P 为 3.2%),该技术依赖于极化转移 Ir-IMes 催化剂上[15N]硝咪乙脲和反氢的同时交换。所呈现的结果为广泛的咪唑类抗生素和化疗药物的高效自旋相关 SABRE-SHEATH 极化铺平了道路。